Angiotensinogen and Megalin Interactions Contribute to Atherosclerosis - Brief Report

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 39, Issue 2, 2019, Pages 150-155

  Ye, Feiming ^a   Wang, Ya ^a   Wu, Congqing ^b   Howatt, Deborah A ^b   Wu, Chia Hua ^b   Balakrishnan, Anju ^b   Mullick, Adam E ^c   Graham, Mark J ^c   Danser, A H Jan ^d   Wang, Jian'An ^a   Daugherty, Alan ^b   Lu, Hong S ^b  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b UNIVERSITY OF KENTUCKY   (United States)

^c ISIS PHARMACEUTICALS   (United States)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

angiotensinogen; angiotensins; atherosclerosis; mice; renin

Indexed keywords

ANGIOTENSIN II; ANGIOTENSINOGEN; ANTISENSE OLIGONUCLEOTIDE; CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; MEGALIN; MESSENGER RNA; PROTEIN; RENIN; SATURATED FATTY ACID; SERUM AMYLOID A; LRP2 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HYPERCHOLESTEROLEMIA; IMMUNOFLUORESCENCE TEST; KIDNEY PROXIMAL TUBULE; LIVER CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN PROTEIN INTERACTION; WESTERN DIET; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; COMPLICATION; PHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANGIOTENSIN II; ANGIOTENSINOGEN; ANIMALS; ATHEROSCLEROSIS; FEMALE; HYPERCHOLESTEROLEMIA; LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-2; MALE; MICE; MICE, INBRED C57BL; OLIGONUCLEOTIDES, ANTISENSE; RENIN-ANGIOTENSIN SYSTEM;

EID: 85059814818     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.118.311817     Document Type: Article

References (51)

1. Rader DJ, Daugherty A. Translating molecular discoveries into new therapies for atherosclerosis. Nature. 2008;451:904-913. doi: 10.1038/nature06796
2. Mazzolai L, Hayoz D. The renin-angiotensin system and atherosclerosis. Curr Hypertens Rep. 2006;8:47-53.
3. van Thiel BS, van der Pluijm I, te Riet L, Essers J, Danser AH. The renin-angiotensin system and its involvement in vascular disease. Eur J Pharmacol. 2015;763(pt A):3-14. doi: 10.1016/j.ejphar.2015.03.090
4. Wu C, Lu H, Cassis LA, Daugherty A. Molecular and pathophysiological features of angiotensinogen: a mini review. N Am J Med Sci (Boston). 2011;4:183-190.
5. Chen X, Howatt DA, Balakrishnan A, Moorleghen JJ, Wu C, Cassis LA, Daugherty A, Lu H. Angiotensin-converting enzyme in smooth muscle cells promotes atherosclerosis. Arterioscler Thromb Vasc Biol. 2016;36:1085-1089.
6. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000;342:145-153.
7. Yusuf S, Teo KK, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P, Anderson C; ONTARGET Investigators. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med. 2008;358:1547-1559. doi: 10.1056/NEJMoa0801317
8. Daugherty A, Manning MW, Cassis LA. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest. 2000;105:1605-1612. doi: 10.1172/JCI7818
9. Weiss D, Kools JJ, Taylor WR. Angiotensin II-induced hypertension accelerates the development of atherosclerosis in apoE-deficient mice. Circulation. 2001;103:448-454.
10. Wu CH, Mohammadmoradi S, Chen JZ, Sawada H, Daugherty A, Lu HS. Renin-angiotensin system and cardiovascular functions. Arterioscler Thromb Vasc Biol. 2018;38:e108-e116. doi: 10.1161/ATVBAHA.118.311282
11. Danser AH. Local renin-angiotensin systems: the unanswered questions. Int J Biochem Cell Biol. 2003;35:759-768.
12. Ichihara A, Kobori H, Nishiyama A, Navar LG. Renal renin-angiotensin system. Contrib Nephrol. 2004;143:117-130.
13. Kobori H, Ozawa Y, Satou R, Katsurada A, Miyata K, Ohashi N, Hase N, Suzaki Y, Sigmund CD, Navar LG. Kidney-specific enhancement of ANG II stimulates endogenous intrarenal angiotensinogen in genetargeted mice. Am J Physiol Renal Physiol. 2007;293:F938-F945. doi: 10.1152/ajprenal.00146.2007
14. Pendergrass KD, Averill DB, Ferrario CM, Diz DI, Chappell MC. Differential expression of nuclear AT1 receptors and angiotensin II within the kidney of the male congenic mRen2. Lewis rat. Am J Physiol Renal Physiol. 2006;290:F1497-F1506. doi: 10.1152/ajprenal.00317.2005
15. Li XC, Zhuo JL. Proximal tubule-dominant transfer of AT(1a) receptors induces blood pressure responses to intracellular angiotensin II in AT(1a) receptor-deficient mice. Am J Physiol Regul Integr Comp Physiol. 2013;304:R588-R598. doi: 10.1152/ajpregu.00338.2012
16. Navar LG, Prieto MC, Satou R, Kobori H. Intrarenal angiotensin II and its contribution to the genesis of chronic hypertension. Curr Opin Pharmacol. 2011;11:180-186. doi: 10.1016/j.coph.2011.01.009
17. Yang T, Xu C. Physiology and pathophysiology of the intrarenal reninangiotensin system: an update. J Am Soc Nephrol. 2017;28:1040-1049.
18. Satou R, Shao W, Navar LG. Role of stimulated intrarenal angiotensinogen in hypertension. Ther Adv Cardiovasc Dis. 2015;9:181-190. doi: 10.1177/1753944715585512
19. Matsusaka T, Niimura F, Shimizu A, Pastan I, Saito A, Kobori H, Nishiyama A, Ichikawa I. Liver angiotensinogen is the primary source of renal angiotensin II. J Am Soc Nephrol. 2012;23:1181-1189. doi: 10.1681/ASN.2011121159
20. Raychowdhury R, Niles JL, McCluskey RT, Smith JA. Autoimmune target in Heymann nephritis is a glycoprotein with homology to the LDL receptor. Science. 1989;244:1163-1165.
21. Saito A, Pietromonaco S, Loo AK, Farquhar MG. Complete cloning and sequencing of rat gp330/"megalin," a distinctive member of the low density lipoprotein receptor gene family. Proc Natl Acad Sci USA. 1994;91:9725-9729.
22. Christensen EI, Birn H. Megalin and cubilin: multifunctional endocytic receptors. Nat Rev Mol Cell Biol. 2002;3:256-266. doi: 10.1038/nrm778
23. Conese M, Nykjaer A, Petersen CM, Cremona O, Pardi R, Andreasen PA, Gliemann J, Christensen EI, Blasi F. alpha-2 Macroglobulin receptor/Ldl receptor-related protein(Lrp)-dependent internalization of the urokinase receptor. J Cell Biol. 1995;131(6 pt 1):1609-1622.
24. Nielsen R, Christensen EI, Birn H. Megalin and cubilin in proximal tubule protein reabsorption: from experimental models to human disease. Kidney Int. 2016;89:58-67. doi: 10.1016/j.kint.2015.11.007
25. Pohl M, Kaminski H, Castrop H, Bader M, Himmerkus N, Bleich M, Bachmann S, Theilig F. Intrarenal renin angiotensin system revisited: role of megalin-dependent endocytosis along the proximal nephron. J Biol Chem. 2010;285:41935-41946. doi: 10.1074/jbc.M110.150284
26. Wu C, Xu Y, Lu H, Howatt DA, Balakrishnan A, Moorleghen JJ, Vander Kooi CW, Cassis LA, Wang JA, Daugherty A. Cys18-Cys137 disulfide bond in mouse angiotensinogen does not affect AngIIdependent functions in vivo. Hypertension. 2015;65:800-805. doi: 10.1161/HYPERTENSIONAHA.115.05166
27. Lu H, Wu C, Howatt DA, Balakrishnan A, Moorleghen JJ, Chen X, Zhao M, Graham MJ, Mullick AE, Crooke RM, Feldman DL, Cassis LA, Vander Kooi CW, Daugherty A. Angiotensinogen exerts effects independent of angiotensin II. Arterioscler Thromb Vasc Biol. 2016;36:256-265. doi: 10.1161/ATVBAHA.115.306740
28. Robinet P, Milewicz DM, Cassis LA, Leeper NJ, Lu HS, Smith JD. Consideration of sex differences in design and reporting of experimental arterial pathology studies-statement from ATVB council. Arterioscler Thromb Vasc Biol. 2018;38:292-303. doi: 10.1161/ATVBAHA.117.309524
29. Daugherty A, Tall AR, Daemen MJAP, Falk E, Fisher EA, García-Cardeña G, Lusis AJ, Owens AP III, Rosenfeld ME, Virmani R; American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology; and Council on Basic Cardiovascular Sciences. Recommendation on design, execution, and reporting of animal atherosclerosis studies: a scientific statement from the American Heart Association. Arterioscler Thromb Vasc Biol. 2017;37:e131-e157. doi: 10.1161/ATV.0000000000000062
30. Lu H, Rateri DL, Daugherty A. Immunostaining of mouse atherosclerotic lesions. Methods Mol Med. 2007;139:77-94.
31. Lu H, Cassis LA, Kooi CW, Daugherty A. Structure and functions of angiotensinogen. Hypertens Res. 2016;39:492-500. doi: 10.1038/hr.2016.17
32. Bing J. Relation between renin substrate and acute phase proteins. Studies of normal and adrenalectomized rats. Acta Pathol Microbiol Scand A. 1972;80:646-650.
33. Luchtefeld M, Schunkert H, Stoll M, et al. Signal transducer of inflammation gp130 modulates atherosclerosis in mice and man. J Exp Med. 2007;204:1935-1944. doi: 10.1084/jem.20070120
34. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med. 1999;340:115-126. doi: 10.1056/NEJM199901143400207
35. Brasier AR, Recinos A III, Eledrisi MS. Vascular inflammation and the renin-angiotensin system. Arterioscler Thromb Vasc Biol. 2002;22:1257-1266.
36. Lusis AJ. Atherosclerosis. Nature. 2000;407:233-241. doi: 10.1038/35025203
37. Lu H, Rateri DL, Feldman DL, Charnigo RJ Jr, Fukamizu A, Ishida J, Oesterling EG, Cassis LA, Daugherty A. Renin inhibition reduces hypercholesterolemia-induced atherosclerosis in mice. J Clin Invest. 2008;118:984-993. doi: 10.1172/JCI32970
38. Chen XC, Lu H, Zhao M, Tashiro K, Cassis LA, Daugherty A. Angiotensinconverting enzyme promotes atherosclerosis through an angiotensin I to angiotensin II pathway involving leukocytes. Arterioscler Thromb Vasc Biol. 2013;33: 2075-2080.
39. Cassis LA, Rateri DL, Lu H, Daugherty A. Bone marrow transplantation reveals that recipient AT1a receptors are required to initiate angiotensin II-induced atherosclerosis and aneurysms. Arterioscler Thromb Vasc Biol. 2007;27:380-386. doi: 10.1161/01.ATV.0000254680.71485.92
40. Koga J, Egashira K, Matoba T, Kubo M, Ihara Y, Iwai M, Horiuchi M, Sunagawa K. Essential role of angiotensin II type 1a receptors in the host vascular wall, but not the bone marrow, in the pathogenesis of angiotensin II-induced atherosclerosis. Hypertens Res. 2008;31:1791-1800. doi: 10.1291/hypres.31.1791
41. Fukuda D, Sata M, Ishizaka N, Nagai R. Critical role of bone marrow angiotensin II type 1 receptor in the pathogenesis of atherosclerosis in apolipoprotein E deficient mice. Arterioscler Thromb Vasc Biol. 2008;28:90-96. doi: 10.1161/ATVBAHA.107.152363
42. Mehta PK, Griendling KK. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol. 2007;292:C82-C97. doi: 10.1152/ajpcell.00287.2006
43. Rateri DL, Moorleghen JJ, Knight V, Balakrishnan A, Howatt DA, Cassis LA, Daugherty A. Depletion of endothelial or smooth muscle cell-specific angiotensin II type 1a receptors does not influence aortic aneurysms or atherosclerosis in LDL receptor deficient mice. PLoS One. 2012;7:e51483. doi: 10.1371/journal.pone.0051483
44. Kobori H, Harrison-Bernard LM, Navar LG. Urinary excretion of angiotensinogen reflects intrarenal angiotensinogen production. Kidney Int. 2002;61:579-585. doi: 10.1046/j.1523-1755.2002.00155.x
45. Yanai K, Saito T, Kakinuma Y, Kon Y, Hirota K, Taniguchi-Yanai K, Nishijo N, Shigematsu Y, Horiguchi H, Kasuya Y, Sugiyama F, Yagami Ki, Murakami K, Fukamizu A. Renin-dependent cardiovascular functions and renin-independent blood-brain barrier functions revealed by renindeficient mice. J Biol Chem. 2000;275:5-8.
46. Ng KK, Vane JR. The conversion of angiotensin I to angiotensin II in vivo. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1968;259:188-189.
47. Taugner R, Hackenthal E, Helmchen U, Ganten D, Kugler P, Marin-Grez M, Nobiling R, Unger T, Lockwald I, Keilbach R. The intrarenal renin-angiotensin-system. An immunocytochemical study on the localization of renin, angiotensinogen, converting enzyme and the angiotensins in the kidney of mouse and rat. Klin Wochenschr. 1982;60:1218-1222.
48. Darby IA, Sernia C. In situ hybridization and immunohistochemistry of renal angiotensinogen in neonatal and adult rat kidneys. Cell Tissue Res. 1995;281:197-206.
49. Nakano D, Kobori H, Burford JL, Gevorgyan H, Seidel S, Hitomi H, Nishiyama A, Peti-Peterdi J. Multiphoton imaging of the glomerular permeability of angiotensinogen. J Am Soc Nephrol. 2012;23:1847-1856. doi: 10.1681/ASN.2012010078
50. Harrison-Bernard LM, El-Dahr SS, O'Leary DF, Navar LG. Regulation of angiotensin II type 1 receptor mRNA and protein in angiotensin II-induced hypertension. Hypertension. 1999;33(1 pt 2):340-346.
51. Roksnoer LC, Heijnen BF, Nakano D, Peti-Peterdi J, Walsh SB, Garrelds IM, van Gool JM, Zietse R, Struijker-Boudier HA, Hoorn EJ, Danser AH. On the origin of urinary renin: a translational approach. Hypertension. 2016;67:927-933. doi: 10.1161/HYPERTENSIONAHA.115.07012